Clinical application of 5-HTa-3R antagonist tropisetron in chemotherapy patients

Table 3 Intensity of delayed vomiting on days 1 and 2 after cisplatin therapy with navoban (20 courses) or metoclopramide plus lorazepam (20 courses )

Vomiting	Navoban (% of courses)	Metoclopramide (% of courses)
Day 1	n = 18	n = 19
No vomiting episodes	75	30
1 to 2 vomiting episodes	10	5
> 2 vomiting episodes	15	65
Day 2	n = 2	n = 5
No vomiting episodes	90	75
1 to 2 vomiting episodes	10	10
> 2 vomiting episodes	0	15